Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Clinical trial NCT03884439 · COMPLETED

Trial details

NCT number: NCT03884439
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Crohn's Disease Ulcerative Colitis

Start date: 2019-03-18
Primary completion: 2024-02-02
Enrollment: 428

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.